PHAXIAM Therapeutics S.A. (ERYP) Financial Statements
PHAXIAM Therapeutics S.A. (ERYP) files with the U.S. Securities and Exchange Commission under CIK 0001624422. 10KGenie shows its annual statements from SEC filings.
Key Figures, Fiscal Year 2022
- Revenue
- 0 EUR
- Net Income
- -228.00 thousand EUR
- Total Assets
- 45.81 million EUR
- Net Cash from Operations
- -31.76 million EUR
Fiscal year ended Dec 31, 2022. Latest periodic SEC filing: Mar 28, 2023. Source: SEC filings (EDGAR XBRL). Amounts in EUR.
Open the full financial statements for ERYP in 10KGenie
Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History